Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

about

Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

Item

http://www.wikidata.org/entity/Q38645013

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

@en

type

Item

label

Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

@en

prefLabel

Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

@en

P1476

Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.

@en

P2093

Eun Jung Shin

http://www.w3.org/2001/XMLSchema#string

Hyo Jin Son

http://www.w3.org/2001/XMLSchema#string

Ji Ae Lee

http://www.w3.org/2001/XMLSchema#string

Onyou Hwang

http://www.w3.org/2001/XMLSchema#string

Se Hee Han

http://www.w3.org/2001/XMLSchema#string

P2860

Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress

Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.

Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1

Behavioral phenotyping of mouse models of Parkinson's disease.

Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism.

An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1

Role of oxidative stress in Parkinson's disease.

P304

633-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10715762.2017.1353688

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28770670

http://www.w3.org/2001/XMLSchema#string